Name: Acute Care
Brand: ECRI
SKU: NIL
Availability: InStock
Rating: 4.6 (5 reviews)

ISMP Newsroom

ISMP

Media Inquiries

For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.

All posts

Press Coverage

Press Coverage

Smart Strategies for Managing COVID-19 Smart Pump Shortages

This article appeared on the General Surgery News website on April 23, 2020.

Press Coverage

Press Coverage

Hospitals Try Glucose Monitors to Reduce Contact with COVID-19 Patients

This article appeared on The Wall Street Journal website on April 20, 2020.

Press Coverage

Press Coverage

The Latest Coronavirus Shortage: Hospital Infusion Pumps

This article appeared on MedTech Dive on April 14, 2020.

Press Coverage

Press Coverage

ISMP Launches COVID-19 Safety Alerts

This article appeared on the Infectious Disease Special Edition website on March 31, 2020.

Press Coverage

Press Coverage

Medical Cannabis Product Labeling Could Increase Med Errors

This article appeared on the Clinical Oncology News website on March 17, 2020.

Press Coverage

Press Coverage

50 Patient Experts to Know / 2020

This article appeared on the Becker’s Hospital Review website on March 11, 2020.

Stay Connected

Get medication safety news, event invitations and updates straight to your inbox!

Social Media

View the Latest from ECRI

News

HANYS Marketplace partners with ECRI to improve patient safety and reduce preventable harm in healthcare

HANYS Marketplace® has partnered with ECRI, a nonprofit organization advancing the safety and quality of healthcare, to provide New York’s hospitals and health systems with evidence-based solutions...

News

ECRI Names Cottage Health Winner of 2026 Health Technology Excellence Award

Innovative blood management initiative recognized for reducing waste through proactive interfacility transfers. ECRI, a nonprofit organization advancing the safety and quality of healthcare, has ho...

News

ECRI & ISMP Statement in Response to PCAC Decision on Compounding Peptides

The FDA Pharmacy Compounding Advisory Committee (PCAC) decided to recommend adding most of the peptides under consideration during its July 23-24, 2026, meeting to the 503A Bulks List, despite subs...

View all